This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2016-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2025
Title: Innovations by Inventor Xia Liu
Introduction
Xia Liu is a notable inventor based in Hopewell Junction, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of eosinophilic esophagitis. With a total of 4 patents to his name, Liu's work is recognized for its potential impact on patient care.
Latest Patents
Liu's latest patents include innovative methods for reducing eosinophilic infiltration by administering an anti-interleukin-4 receptor (IL4R) antibody. These methods aim to treat, prevent, or reduce the severity of eosinophilic esophagitis. The therapeutic compositions he developed comprise an interleukin-4 receptor (IL-4Rα) inhibitor, such as an anti-IL-4Rα antibody. Another patent focuses on similar methods of treating eosinophilic esophagitis by administering an antibody that inhibits the interleukin-4 receptor (IL-4R).
Career Highlights
Xia Liu is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to advance his research and innovations. His work is pivotal in developing therapies that address complex medical conditions.
Collaborations
Liu collaborates with talented professionals in his field, including Ana Kostic and Ludmila Kelly, who contribute to the innovative environment at Regeneron Pharmaceuticals.
Conclusion
Xia Liu's contributions to medical science through his patents and collaborations highlight his commitment to improving treatment options for patients. His work exemplifies the importance of innovation in addressing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile